Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance

E-ISSN： 1875-5550|16|4|270-278

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.16, Iss.4, 2015-06, pp. : 270-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells

By Karaca Burcak

Molecular Biology Reports, Vol. 40, Iss. 6, 2013-06 ,pp. : 3925-3933

Springer Publishing Company

Access to resources Recommend Favorite

The overexpression of P21-activated kinase 5 (PAK5) promotes paclitaxel-chemoresistance of epithelial ovarian cancer

By Li Diyou Yao Xiaohong Zhang Ping

Molecular and Cellular Biochemistry, Vol. 383, Iss. 1-2, 2013-11 ,pp. : 191-199

Springer Publishing Company

Access to resources Recommend Favorite

Pertuzumab for the treatment of ovarian cancer

By Langdon Simon P Faratian Dana Nagumo Yoko Mullen Peter Harrison David J

Expert Opinion on Biological Therapy, Vol. 10, Iss. 7, 2010-07 ,pp. : 1113-1120

Informa Healthcare

Access to resources Recommend Favorite

Abagovomab for ovarian cancer

By Pfisterer Jacobus Harter Philipp Simonelli Cecilia Peters Martin Berek Jonathan Sabbatini Paul du Bois Andreas

Expert Opinion on Biological Therapy, Vol. 11, Iss. 3, 2011-03 ,pp. : 395-403

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy of ovarian cancer

By Kirby Tyler O Alvarez Ronald Huh Warner

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 409-417

Informa Healthcare

Access to resources Recommend Favorite